NEW YORK (GenomeWeb) - MetaStat today announced an agreement with the Kaiser Foundation to access tumor samples and clinical data from Kaiser Permanente hospitals.

Under the terms of the agreement, MetaStat will receive de-identified tissue samples, clinical data, and medical histories for up to 500 patients with or without metastatic breast cancer. The firm will test these samples with its MetaSite Breast and MenaCalc Breast diagnostic assays, which aim to predict systemic metastasis.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.